Structures by: Dayananda A. S.
Total: 30
C15H15NOS
C15H15NOS
Crystals (2012) 2, 3 1058-1066
a=9.2080(4)Å b=14.0485(7)Å c=10.3826(6)Å
α=90.00° β=90.00° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.3738(7)Å b=10.8501(7)Å c=11.8301(9)Å
α=90.00° β=98.615(7)° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.6092(8)Å b=10.8355(8)Å c=11.1346(9)Å
α=90.00° β=98.643(6)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.6941(6)Å b=10.7909(4)Å c=8.6586(3)Å
α=90.00° β=102.184(4)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.5187(8)Å b=10.9358(5)Å c=8.8141(4)Å
α=90.00° β=101.245(5)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.1766(19)Å b=11.2809(14)Å c=8.9334(14)Å
α=90.00° β=98.726(13)° γ=90.00°
Paliperidone
C23H27FN4O3
Acta Crystallographica Section E (2011) 67, 11 o2945-o2946
a=6.85370(10)Å b=21.5613(5)Å c=15.3472(3)Å
α=90.00° β=113.8570(10)° γ=90.00°
(<i>E</i>)-1-(2,5-Dichlorothiophen-3-yl)ethanone [8-(trifluoromethyl)quinolin-4-yl]hydrazone
C16H10Cl2F3N3S
Acta Crystallographica Section E (2012) 68, 3 o790
a=7.687(2)Å b=14.392(5)Å c=14.360(5)Å
α=90.00° β=95.053(9)° γ=90.00°
Methyl 2,2-diphenyl-2-(prop-2-yn-1-yloxy)acetate
C18H16O3
Acta Crystallographica Section E (2012) 68, 3 o874
a=12.6771(17)Å b=9.2410(13)Å c=12.7055(18)Å
α=90.00° β=93.090(3)° γ=90.00°
Ethyl <i>N</i>-(2-benzoyl-4-chlorophenyl)ethanecarboximidate
C17H16ClNO2
Acta Crystallographica Section E (2012) 68, 3 o916
a=7.9674(11)Å b=8.6993(17)Å c=11.596(2)Å
α=104.499(17)° β=94.871(14)° γ=95.001(14)°
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium bis(trichloroacetate) 0.4-hydrate
C17H20F2N22,2(C2Cl3O2),0.4(H2O)
Acta Crystallographica Section E (2012) 68, 4 o968
a=8.8101(7)Å b=33.555(3)Å c=9.4453(7)Å
α=90.00° β=108.723(2)° γ=90.00°
5-(Biphenyl-4-yl)-3-(3-methoxybenzylidene)furan-2(3<i>H</i>)-one
C24H18O3
Acta Crystallographica Section E (2011) 67, 9 o2294-o2295
a=19.8766(8)Å b=6.9914(3)Å c=13.2603(6)Å
α=90.00° β=107.735(4)° γ=90.00°
2-Methyl-4-(4-methylpiperazin-4-ium-1-yl)-10<i>H</i>- thieno[2,3-<i>b</i>][1,5]benzodiazepinium bis(2,4,6-trinitrophenolate)
C17H22N4S2,2(C6H2N3O7)
Acta Crystallographica Section E (2013) 69, 2 o232-o233
a=22.1660(4)Å b=12.7349(2)Å c=23.3951(4)Å
α=90.00° β=90.00° γ=90.00°
4-(4-Chlorophenyl)-4-hydroxypiperidinium benzoate
C11H15ClNO,C7H5O2
Acta Crystallographica Section E (2011) 67, 6 o1436
a=9.6235(12)Å b=10.0971(16)Å c=10.2251(14)Å
α=99.608(12)° β=108.748(13)° γ=113.357(14)°
<i>N</i>,<i>N</i>-Dimethyl-3-oxo-3-(thiophen-2-yl)propanaminium chloride
C9H14NOS,Cl
Acta Crystallographica Section E (2011) 67, 9 o2271
a=5.8663(3)Å b=27.0109(9)Å c=7.1385(4)Å
α=90.00° β=110.767(6)° γ=90.00°
2-[(<i>E</i>)-1-(4-methylphenyl)-3-(pyrrolidin-1-ium- 1-yl)prop-1-enyl]pyridinium bis(2,4,6-trinitrophenolate)
C19H24N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 9 o2502
a=15.0542(7)Å b=12.7489(5)Å c=17.1446(7)Å
α=90.00° β=100.218(4)° γ=90.00°
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium 2-(2-phenylethyl)benzoate
C17H19F2N2,C15H13O2
Acta Crystallographica Section E (2011) 67, 10 o2783-o2784
a=8.2330(2)Å b=35.5366(10)Å c=10.1505(3)Å
α=90.00° β=112.9250(10)° γ=90.00°
4,4'-Difluorobenzhydryl piperazinium picrate
C17H19F2N2,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 10 o2587-o2588
a=8.9425(2)Å b=11.8286(2)Å c=23.0922(4)Å
α=90.00° β=105.7200(10)° γ=90.00°
2-Amino-<i>N</i>-[3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl]acetamide
C15H15ClN2O2S
Acta Crystallographica Section E (2012) 68, 2 o547-o548
a=13.9784(11)Å b=13.5565(11)Å c=8.3334(7)Å
α=90.00° β=91.2330(10)° γ=90.00°
Loperamide monohydrate
C29H33ClN2O2,H2O
Acta Crystallographica Section E (2012) 68, 2 o539-o540
a=16.7869(4)Å b=15.1506(6)Å c=20.6617(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-5-(2-Chlorophenyl)-7-ethyl-2-oxo-2,3-dihydro-1<i>H</i>-thieno[2,3-<i>e</i>][1,4]diazepin-4-ium 2,4,6-trinitrophenolate
C15H14ClN2OS,C6H2N3O7
Acta Crystallographica Section E (2012) 68, 2 o516-o517
a=10.5704(2)Å b=20.0667(5)Å c=11.3741(2)Å
α=90.00° β=110.6660(10)° γ=90.00°
Deferasirox
C21H15N3O4,C3H7NO
Acta Crystallographica Section E (2012) 68, 3 o792-o793
a=8.8172(8)Å b=32.669(3)Å c=7.6900(7)Å
α=90.00° β=94.901(2)° γ=90.00°
4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium 2-hydroxybenzoate 2-hydroxybenzoic acid monosolvate
C17H19F2N2,C7H5O3,C7H6O3
Acta Crystallographica Section E (2012) 68, 4 o1180
a=33.157(4)Å b=10.3007(14)Å c=20.105(3)Å
α=90.00° β=124.447(2)° γ=90.00°
Triprolidinium dichloranilate--chloranilic acid--methanol--water (2/1/2/2)
C19H24N22,2(C6HCl2O4),0.5(C6H2Cl2O4),CH4O,H2O
Acta Crystallographica Section E (2012) 68, 4 o1037-o1038
a=9.1633(2)Å b=32.3720(7)Å c=12.9834(4)Å
α=90° β=106.685(3)° γ=90°
(<i>R</i>)-Doxylaminium (<i>R</i>,<i>R</i>)-tartrate
C17H23N2O,C4H5O6
Acta Crystallographica Section E (2012) 68, 4 o1054-o1055
a=7.4419(4)Å b=18.4394(8)Å c=8.3517(4)Å
α=90.00° β=108.301(5)° γ=90.00°
Cinnarizinium 3,5-dinitrosalicylate
C26H29N2,C7H3N2O7
Acta Crystallographica Section E (2012) 68, 4 o1165-o1166
a=14.5648(3)Å b=12.9374(3)Å c=16.1619(3)Å
α=90.00° β=103.9000(10)° γ=90.00°
1-{4-[Bis(4-fluorophenyl)methyl]piperazin-1-yl}ethanone
C19H20F2N2O
Acta Crystallographica Section E (2012) 68, 7 o2237
a=10.1701(5)Å b=16.5521(5)Å c=11.1690(5)Å
α=90.0° β=114.690(5)° γ=90.0°
1-[Bis(4-fluorophenyl)methyl]piperazine
C17H18F2N2
Acta Crystallographica Section E (2012) 68, 9 o2817
a=12.1574(5)Å b=8.8559(2)Å c=13.8604(4)Å
α=90.00° β=93.355(3)° γ=90.00°
(3-Chloropropyl)triphenylphosphonium bromide
C21H21ClP,Br
Acta Crystallographica Section E (2012) 68, 11 o3115
a=11.0708(2)Å b=10.0435(2)Å c=17.5740(4)Å
α=90.00° β=104.9730(10)° γ=90.00°
Cinnarizinium bis(<i>p</i>-toluenesulfonate) dihydrate
C26H30N22,2(C7H7O3S),2(H2O)
Acta Crystallographica Section E (2013) 69, 4 o485-o486
a=10.0845(2)Å b=14.6026(3)Å c=25.8591(6)Å
α=90.00° β=93.414(2)° γ=90.00°